WELL Health Technologies (TSE:WELL) Reaches New 12-Month High on Analyst Upgrade

WELL Health Technologies Corp. (TSE:WELL) shares hit a new 52-week high on Friday after CIBC raised their price target on the stock from C$5.00 to C$5.25. The company traded as high as C$5.33 and last traded at C$5.28, with a volume of 2508925 shares. The stock had previously closed at C$4.93.

Separately, Ventum Financial cut their price objective on shares of WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating on the stock in a report on Tuesday, October 29th. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of C$7.00.

WELL Health Technologies Trading Up 8.3 %

The company has a market cap of C$1.33 billion, a P/E ratio of 9.28, a P/E/G ratio of -1.93 and a beta of 1.20. The stock’s 50-day moving average is C$4.43 and its two-hundred day moving average is C$4.32. The company has a debt-to-equity ratio of 41.57, a current ratio of 1.25 and a quick ratio of 1.02.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.